Immune Treatments for Alcohol Use Disorder: A Translational Framework.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Brain, behavior, and immunity

• Publication date

  2021-07-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbi.2021.07.023PMID 34343618PMCID PMC9044974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurosteroid allopregnanolone (3α,5α-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors

  2021cited by this paper
• The Role of Glia in Addiction: Dopamine as a Modulator of Glial Responses in Addiction

  2021cited by this paper
• Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial

  2021cited by this paper
• Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety

  2020cited by this paper
• What Is Recovery?

  2020cited by this paper
• Cortical astrocytes regulate ethanol consumption and intoxication in mice

  2020cited by this paper
• Epigenetic Regulation of GABAergic Neurotransmission and Neurosteroid Biosynthesis in Alcohol Use Disorder

  2020cited by this paper
• The future of translational research on alcohol use disorder

  2020cited by this paper
• Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder.

  2020cited by this paper
• Increased transcription of TSPO, HDAC2, and HDAC6 in the amygdala of males with alcohol use disorder

  2020cited by this paper
• Microglia Control Escalation of Drinking in Alcohol-Dependent Mice: Genomic and Synaptic Drivers.

  2020cited by this paper
• PPARγ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study

  2020cited by this paper
• Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials

  2020cited by this paper
• Activation of peroxisome proliferator-activated receptor γ reduces alcohol drinking and seeking by modulating multiple mesocorticolimbic regions in rats

  2020cited by this paper
• Alcohol use disorder and circulating cytokines: A systematic review and meta-analysis.

  2020cited by this paper
• Development of BTK inhibitors for the treatment of B-cell malignancies

  2019cited by this paper
• Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.

  2019cited by this paper
• GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance

  2019cited by this paper
• A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

  2019cited by this paper
• Targeting neuroinflammation with minocycline in heavy drinkers

  2019cited by this paper
• Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review

  2019cited by this paper
• Neuroimmune signaling in alcohol use disorder

  2019cited by this paper
• Single cell transcriptome profiling of the human alcohol-dependent brain

  2019cited by this paper
• Mechanisms of Persistent Neurobiological Changes Following Adolescent Alcohol Exposure: NADIA Consortium Findings

  2019cited by this paper
• Glial gene networks associated with alcohol dependence

  2019cited by this paper
• Effects of pharmacologically targeting neuroimmune pathways on alcohol drinking in mice selectively bred to drink to intoxication.

  2019cited by this paper
• Stress and drug abuse-related disorders: the promising therapeutic value of neurosteroids Focus on Pregnenolone-Progesterone-Allopregnanolone pathway.

  2019cited by this paper
• Inflammatory pathways in alcoholic steatohepatitis.

  2019cited by this paper
• Mindfulness practice predicts interleukin-6 responses to a mindfulness-based alcohol relapse prevention intervention.

  2019cited by this paper
• Aspirin and N‐acetylcysteine co‐administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation‐oxidative stress self‐perpetuation

  2019cited by this paper
• Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.

  2019cited by this paper
• Innate Immune Signaling and Alcohol Use Disorders.

  2018cited by this paper
• Apremilast Alters Behavioral Responses to Ethanol in Mice: I. Reduced Consumption and Preference

  2018cited by this paper
• Human Binge Alcohol Intake Inhibits TLR4–MyD88 and TLR4–TRIF Responses but Not the TLR3–TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles

  2018cited by this paper
• Apremilast Alters Behavioral Responses to Ethanol in Mice: II. Increased Sedation, Intoxication, and Reduced Acute Functional Tolerance

  2018cited by this paper
• Role of the innate immune system in the neuropathological consequences induced by adolescent binge drinking

  2018cited by this paper
• Neuroactive Steroid (3&agr;,5&agr;)3‐hydroxypregnan‐20‐one (3&agr;,5&agr;‐THP) and Pro‐inflammatory Cytokine MCP‐1 Levels in Hippocampus CA1 are Correlated with Voluntary Ethanol Consumption in Cynomolgus Monkey

  2018cited by this paper
• The GABAA Receptor α2 Subunit Activates a Neuronal TLR4 Signal in the Ventral Tegmental Area that Regulates Alcohol and Nicotine Abuse

  2018cited by this paper
• Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

  2018cited by this paper
• Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorder

  2018cited by this paper
• Cannabidiol reduces ethanol consumption, motivation and relapse in mice

  2018cited by this paper
• The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

  2018cited by this paper
• Minocycline in Alcohol Withdrawal Induced Anxiety and Alcohol Relapse in Rats.

  2018cited by this paper
• The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial.

  2018cited by this paper
• Antagonising TLR4‐TRIF signalling before or after a low‐dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood

  2018cited by this paper
• Effect of N‐acetylcysteine on motivation, seeking and relapse to ethanol self‐administration

  2018cited by this paper
• Chronic ethanol consumption: role of TLR3/TRIF‐dependent signaling

  2018cited by this paper
• Adolescent binge ethanol-induced loss of basal forebrain cholinergic neurons and neuroimmune activation are prevented by exercise and indomethacin

  2018cited by this paper
• Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions

  2018cited by this paper
• Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol.

  2018cited by this paper
• Persistent Adult Neuroimmune Activation and Loss of Hippocampal Neurogenesis Following Adolescent Ethanol Exposure: Blockade by Exercise and the Anti-inflammatory Drug Indomethacin

  2018cited by this paper
• Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer

  2018cited by this paper
• Design and Conduct Considerations for First‐in‐Human Trials

  2018cited by this paper
• Baseline Patterns of Substance Use Disorder Severity and Depression and Anxiety Symptoms Moderate the Efficacy of Mindfulness-Based Relapse Prevention

  2017cited by this paper
• The role of neuroimmune signaling in alcoholism.

  2017cited by this paper
• Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα

  2017cited by this paper
• Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents

  2017cited by this paper
• Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity.

  2017cited by this paper
• The Neuroimmune Basis of Excessive Alcohol Consumption

  2017cited by this paper
• Toll-like receptor signaling and stages of addiction

  2017cited by this paper
• Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF‐kB danger signaling in rat frontal cortex and depressive‐like behavior induced by ethanol binge administration

  2017cited by this paper
• Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury

  2017cited by this paper
• Genome-Wide Expression Profiles Drive Discovery of Novel Compounds that Reduce Binge Drinking in Mice

  2017cited by this paper
• Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans

  2017cited by this paper
• β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.

  2017cited by this paper
• Protection against alcohol-induced neuronal and cognitive damage by the PPARγ receptor agonist pioglitazone.

  2017cited by this paper
• The peroxisome proliferator‐activated receptor alpha agonist fenofibrate attenuates alcohol self‐administration in rats

  2017cited by this paper
• Glial and neuroinflammatory targets for treating substance use disorders.

  2017cited by this paper
• Nalmefene Prevents Alcohol‐Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4

  2017cited by this paper
• Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial

  2017cited by this paper
• N-acetylcysteine Prevents Alcohol Related Neuroinflammation in Rats

  2017cited by this paper
• Alcohol intake in two different mouse drinking models after recovery from the lipopolysaccharide-induced sickness reaction.

  2017cited by this paper
• The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice

  2017cited by this paper
• Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis

  2017cited by this paper
• Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88

  2017cited by this paper
• Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research.

  2016cited by this paper
• Neuroinflammation: the devil is in the details

  2016cited by this paper
• Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents

  2016cited by this paper
• Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression.

  2016cited by this paper
• Mind-body therapies and control of inflammatory biology: A descriptive review.

  2016cited by this paper
• TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation

  2016cited by this paper
• PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption.

  2016cited by this paper
• Role of the satiety factor oleoylethanolamide in alcoholism

  2016cited by this paper
• Medications for Alcohol Use Disorder.

  2016cited by this paper
• Involvement of TLR4 in the long-term epigenetic changes, rewarding and anxiety effects induced by intermittent ethanol treatment in adolescence.

  2016cited by this paper
• Evaluation of TLR4 Inhibitor, T5342126, in Modulation of Ethanol-Drinking Behavior in Alcohol-Dependent Mice.

  2016cited by this paper
• PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.

  2016cited by this paper
• Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers.

  2016cited by this paper
• The role of the gut-brain axis in alcohol use disorders.

  2016cited by this paper
• Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development.

  2016cited by this paper
• The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

  2016cited by this paper
• Inhibition of IKKβ Reduces Ethanol Consumption in C57BL/6J Mice

  2016cited by this paper
• Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2.

  2015cited by this paper
• Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking

  2015cited by this paper
• The role of inflammation in depression: from evolutionary imperative to modern treatment target

  2015cited by this paper
• Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence

  2015cited by this paper
• Chronic Ethanol Exposure Produces Time- and Brain Region-Dependent Changes in Gene Coexpression Networks

  2015cited by this paper
• CRF-Amplified Neuronal TLR4/MCP-1 Signaling Regulates Alcohol Self-Administration

  2015cited by this paper
• Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4

  2015cited by this paper
• A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance.

  2015cited by this paper

• Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials

  2026cites this paper
• Metabolic dysfunction and alcohol-associated liver disease (MetALD)

  2025cites this paper
• MAO-B status in alcohol use disorder: a [11C]SL25.1188 PET imaging study of putative astrogliosis.

  2025cites this paper
• Evaluating the Long‐Term Benefits of Medications for Alcohol Use Disorder in Alcohol‐Associated Cirrhosis

  2025cites this paper
• Astrocyte alterations and dysfunction in alcohol use disorder: A comprehensive scoping review of clinical postmortem and preclinical evidence.

  2025cites this paper
• Variations in alcohol craving and negative mood during a clinical trial of ibudilast for alcohol use disorder

  2025cites this paper
• Crosstalk between alcohol use disorder and obesity: two sides of the same coin?

  2025cites this paper
• Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon

  2025cites this paper
• CB1 receptors on a subset of vagal afferent neurons modulate voluntary ethanol intake in mice

  2025cites this paper
• Alcohol Use Disorder-Associated Pain: Clinical and Preclinical Evidence.

  2025cites this paper
• Behavioral Neurobiology of Alcohol Addiction: A Decade of Great Challenges, New Hopes, and Hypes.

  2025cites this paper
• Thiamine Deficiency and Neuroinflammation Are Important Contributors to Alcohol Use Disorder

  2025cites this paper
• Cortical reactive microglia activate astrocytes, increasing neurodegeneration in human alcohol use disorder

  2025cites this paper
• A Neuroimmune Modulator for Alcohol Use Disorder

  2025cites this paper
• Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches

  2025cites this paper
• Utilizing Blood Inflammatory Markers in Alcohol Studies: Considerations and Recommendations for Study Design, Sample Collection, and Data Analysis.

  2025cites this paper
• Binge ethanol consumption can be attenuated by systemic administration of minocycline and is associated with enhanced neuroinflammation in the central amygdala.

  2024cites this paper
• Novel insight into the lipid network of plasma extracellular vesicles reveal sex-based differences in the lipidomic profile of alcohol use disorder patients

  2024cites this paper
• Neuroimmune modulators as novel pharmacotherapies for substance use disorders

  2024cites this paper
• Knockdown of Tlr3 in dorsal striatum reduces ethanol consumption and acute functional tolerance in male mice.

  2024cites this paper
• Activation of STING signaling aggravates chronic alcohol exposure‐induced cognitive impairment by increasing neuroinflammation and mitochondrial apoptosis

  2024cites this paper
• Epigenetic regulation of microglia and neurons by proinflammatory signaling following adolescent intermittent ethanol (AIE) exposure and in human AUD

  2024cites this paper
• Effect of rifampicin on TLR4-signaling pathways in the nucleus accumbens of the rat brain during abstinence of long-term alcohol treatment.

  2024cites this paper
• Two-Month Voluntary Ethanol Consumption Promotes Mild Neuroinflammation in the Cerebellum but Not in the Prefrontal Cortex, Hippocampus, or Striatum of Mice

  2024cites this paper
• Novel medications for problematic alcohol use

  2024cites this paper
• Shared and unique 3D genomic features of substance use disorders across multiple cell types

  2024cites this paper
• Alcohol, HMGB1, and Innate Immune Signaling in the Brain

  2024influential citation
• Elevations in interleukin-8 levels in individuals with alcohol use disorder and clinical insomnia symptoms.

  2024cites this paper
• Does sex moderate the effects of early life stress on peripheral inflammation in alcohol use disorder? A preliminary investigation.

  2024cites this paper
• Increased white blood cell in young adults with family histories of alcohol and other substance use disorders

  2024cites this paper
• Investigating the relationship between early life adversity, inflammation and alcohol use

  2023cites this paper
• Chronic ethanol induces a pro-inflammatory switch in interleukin-1β regulation of GABAergic signaling in the medial prefrontal cortex of male mice.

  2023cites this paper
• Differential Effects of Nicotine, Alcohol, and Coexposure on Neuroimmune-Related Protein and Gene Expression in Corticolimbic Brain Regions of Rats.

  2023cites this paper
• Drosophila Stat92E Signaling Following Pre-exposure to Ethanol

  2023cites this paper
• Central Effects of Peripherically Introduced Immune Cells Modulated by an Original Anticonvulsant in Experimental Alcoholism

  2023cites this paper
• New insights into the molecular basis of alcohol abstinence and relapse in alcohol-associated liver disease.

  2023cites this paper
• Alcohol and the Brain–Gut Axis: The Involvement of Microglia and Enteric Glia in the Process of Neuro-Enteric Inflammation

  2023cites this paper
• Lipid network of plasma extracellular vesicles reveals sex-based differences in the lipidomic profile from patients with alcohol use disorder

  2023cites this paper
• Glial Dysfunction in Substance Use Disorders. New insights from PET and MR Imaging

  2023cites this paper
• Integrative Pharmacology in the Treatment of Substance Use Disorders

  2023cites this paper
• Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge.

  2023cites this paper
• The Central Effects of Peripherally Administered Immune Cells Modulated by an Original Anticonvulsant in Experimental Alcoholism

  2023cites this paper
• The Role of Toll and Nonnuclear NF-κB Signaling in the Response to Alcohol

  2023cites this paper
• Neuroimmune pathways as targets to reduce alcohol consumption.

  2022cites this paper
• TLR3 activation with poly I:C exacerbates escalated alcohol consumption in dependent male C57BL/6J mice

  2022cites this paper
• Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial

  2022cites this paper
• The effect of neuroimmune modulation on subjective response to alcohol in the natural environment.

  2022cites this paper
• Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood

  2022cites this paper
• Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

  2022cites this paper
• Receptor Protein Tyrosine Phosphatase β/ζ regulates loss of neurogenesis in the mouse hippocampus following adolescent acute ethanol exposure.

  2022cites this paper
• Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders

  2021cites this paper